Philips Announces Changes to its Executive Committee

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) has announced the appointment of Jeroen Tas as Chief Innovation & Strategy Officer to accelerate Philips' transition to a solutions company, driving innovations in systems, smart devices, software and services to improve people's lives. Effective immediately, Jeroen Tas is responsible for strategy, research & development, design, medical affairs, sustainability, platforms, emerging businesses and process excellence to bring innovations to market. In his new role, Jeroen Tas replaces Jean Botti, who has left the company.

At the same time, Philips has appointed Carla Kriwet as Chief Business Leader of the Connected Care & Health Informatics businesses and new member of the Executive Committee. In this role, she succeeds Jeroen Tas with immediate effect. In addition, she will continue to lead the Business Group Patient Care & Monitoring Solutions, which is part of the Connected Care & Health Informatics segment.

As a further change to Philips' Executive Committee, Ronald de Jong has been appointed as Global Head of Human Resources (HR) per April 1, 2017. He succeeds Denise Haylor, who has decided to leave Philips for family reasons. A separate announcement will be made with regard to Ronald de Jong’s succession as Chief Market Leader.

"In 2016, Philips made significant progress with its strategic transformation to a focused leader in health technology and we have good momentum," said Frans van Houten, Chief Executive Officer of Royal Philips. "Looking ahead, there is an opportunity for us to accelerate Philips' transition to a customer-centric solutions company, and further leverage advanced informatics, artificial intelligence and the Internet of Things into our health propositions and our way of working. I am convinced that with the new responsibilities of Jeroen, Carla and Ronald within Philips' Executive Committee, we will be able to accelerate on our journey. We are thankful for Denise's significant contribution to shape the HR function at Philips over the last few years and we would like to wish her every success in her next endeavors. We would also like to wish Jean success for the future."

Jeroen Tas has over 30 years of experience as an entrepreneur and executive in the financial services, information technology and healthcare industries. In his previous role, he was successful in turning around and growing our Philips' healthcare IT business and establishing HealthSuite as the new open industry standard for the 'Internet of Things' in healthcare.

Since 2015, Carla Kriwet has successfully driven profitable growth and innovation in the Business Group Patient Care & Monitoring Solutions. Among other important achievements, she seeded new growth initiatives based on connected wearable biosensors and established new business partnerships.

As Philips' Chief Market Leader, Ronald de Jong has led the transformation of Philips' markets organization in the last five years towards a locally relevant, customer-centric solutions approach, significantly contributing to Philips’ solid growth and profitability improvement in 2016. In doing so, his team has built new capabilities, driven change management, and attracted new talent.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...